{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:17:50Z","timestamp":1784679470356,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The identification of pathologically altered neutrophil granulocyte migration patterns bears strong potential for surveillance and prognostic scoring of diseases. We recently identified a strong correlation between impaired neutrophil motility and the disease stage of myelodysplastic syndrome (MDS). Here, we apply this assay to study quantitively increased neutrophils of a patient suffering from a rare leukemia subtype, atypical chronic myeloid leukemia (aCML).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 69-year-old male was analyzed in this study. Besides routine analyses, we purified the patient\u2019s neutrophils from peripheral whole blood and studied their migration behavior using time-lapse video microscopy in a standardized assay. These live cell migration analyses also allowed for the quantification of cell morphology. Furthermore, the cells were stained for the markers CD15, CD16, fMLPR, CXCR1 and CXCR2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Despite cytoreductive therapy with hydroxyurea, the patient\u2019s WBC and ANC were poorly controlled and severe dysgranulopoiesis with hypogranularity was observed. Neutrophils displayed strongly impaired migration when compared to healthy controls and migrating cells exhibited a more flattened-out morphology than control neutrophils. Because of a detected CSF3R (p.T618I) mutation and constitutional symptoms treatment with ruxolitinib was initiated. Within 1 week of ruxolitinib treatment, the cell shape normalized and remained indistinguishable from healthy control neutrophils. However, neutrophil migration did not improve over the course of ruxolitinib therapy but was strikingly altered shortly before a sinusitis with fever and bleeding from a gastric ulcer. Molecular work-up revealed that under ruxolitinib treatment, the CSF3R clone was depleted, yet the expansion of a NRAS mutated subclone was promoted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results demonstrate the usefulness of neutrophil migration analyses to uncover corresponding alterations of neutrophil migration in rare myeloid neoplasms. Furthermore, in addition to monitoring migration the determination of morphological features of live neutrophils might represent a useful tool to monitor the effectiveness of therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07130-7","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T08:06:02Z","timestamp":1594627562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib"],"prefix":"10.1186","volume":"20","author":[{"given":"Lea","family":"Bornemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlyn","family":"Sobczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haverkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gunzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-6732","authenticated-orcid":false,"given":"Joachim R.","family":"G\u00f6thert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"7130_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","volume":"9","author":"TN Mayadas","year":"2014","unstructured":"Mayadas TN, Cullere X, Lowell CA. The multifaceted functions of neutrophils. Annu Rev Pathol. 2014;9:181\u2013218.","journal-title":"Annu Rev Pathol"},{"issue":"Suppl 1","key":"7130_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0b013e3181818466","volume":"30","author":"JC Alves-Filho","year":"2008","unstructured":"Alves-Filho JC, de Freitas A, Spiller F, Souto FO, Cunha FQ. The role of neutrophils in severe sepsis. Shock. 2008;30(Suppl 1):3\u20139.","journal-title":"Shock."},{"issue":"4","key":"7130_CR3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/ALN.0b013e31820ca911","volume":"114","author":"M Adamzik","year":"2011","unstructured":"Adamzik M, Frey UH, Mohlenkamp S, Scherag A, Waydhas C, Marggraf G, et al. Aquaporin 5 gene promoter--1364A\/C polymorphism associated with 30-day survival in severe sepsis. Anesthesiology. 2011;114(4):912\u20137.","journal-title":"Anesthesiology."},{"issue":"16","key":"7130_CR4","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1073\/pnas.1324043111","volume":"111","author":"EK Sackmann","year":"2014","unstructured":"Sackmann EK, Berthier E, Schwantes EA, Fichtinger PS, Evans MD, Dziadzio LL, et al. Characterizing asthma from a drop of blood using neutrophil chemotaxis. Proc Natl Acad Sci U S A. 2014;111(16):5813\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"7130_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2796.2012.02588.x","volume":"272","author":"J Marsal","year":"2012","unstructured":"Marsal J, Agace WW. Targeting T-cell migration in inflammatory bowel disease. J Intern Med. 2012;272(5):411\u201329.","journal-title":"J Intern Med"},{"issue":"3","key":"7130_CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0404.2007.00829.x","volume":"116","author":"A Dressel","year":"2007","unstructured":"Dressel A, Mirowska-Guzel D, Gerlach C, Weber F. Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta1a. Acta Neurol Scand. 2007;116(3):164\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"7130_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bjh.12608","volume":"164","author":"M Gunzer","year":"2014","unstructured":"Gunzer M. Traps and hyper inflammation - new ways that neutrophils promote or hinder survival. Br J Haematol. 2014;164(2):189\u201399.","journal-title":"Br J Haematol"},{"issue":"3","key":"7130_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159\u201375.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"7130_CR9","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/ijc.25892","volume":"129","author":"S Trellakis","year":"2011","unstructured":"Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2011;129(9):2183\u201393.","journal-title":"Int J Cancer"},{"issue":"2","key":"7130_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1189\/jlb.0310162","volume":"89","author":"S Brandau","year":"2011","unstructured":"Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol. 2011;89(2):311\u20137.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"7130_CR11","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/ijc.30671","volume":"140","author":"CR Millrud","year":"2017","unstructured":"Millrud CR, K\u00e5gedal \u00c5, Kumlien Geor\u00e9n S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140(11):2557\u201367.","journal-title":"Int J Cancer"},{"issue":"11","key":"7130_CR12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41590-018-0229-5","volume":"19","author":"S Patel","year":"2018","unstructured":"Patel S, Fu S, Mastio J, Dominguez GA, Purohit A, Kossenkov A, et al. Unique pattern of neutrophil migration and function during tumor progression. Nat Immunol. 2018;19(11):1236\u201347.","journal-title":"Nat Immunol"},{"key":"7130_CR13","first-page":"ji1801071","volume":"1","author":"M Schuster","year":"2018","unstructured":"Schuster M, Moeller M, Bornemann L, Bessen C, Sobczak C, Schmitz S, et al. Surveillance of myelodysplastic syndrome via migration analyses of blood neutrophils: a potential prognostic tool. J Immunol. 2018;1:ji1801071.","journal-title":"J Immunol"},{"issue":"3","key":"7130_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.leukres.2011.11.012","volume":"36","author":"L Fianchi","year":"2012","unstructured":"Fianchi L, Leone G, Posteraro B, Sanguinetti M, Guidi F, Valentini CG, et al. Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome. Leuk Res. 2012;36(3):331\u20133.","journal-title":"Leuk Res"},{"key":"7130_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/asheducation-2015.1.264","volume":"2015","author":"KH Dao","year":"2015","unstructured":"Dao KH, Tyner JW. What\u2019s different about atypical CML and chronic neutrophilic leukemia? Hematol Am Soc Hematol Educ Program. 2015;2015:264\u201371.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"20","key":"7130_CR16","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood."},{"issue":"7","key":"7130_CR17","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","volume":"22","author":"A Orazi","year":"2008","unstructured":"Orazi A, Germing U. The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia. 2008;22(7):1308\u201319.","journal-title":"Leukemia."},{"key":"7130_CR18","first-page":"80","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"J Vardiman","year":"2008","unstructured":"Vardiman J, Bennett J, Bain B, Brunning R, Thiele J. Atypical chronic myeloid leukaemia, BCR-ABL1 negative. In: WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 80\u20131."},{"issue":"6","key":"7130_CR19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood-2016-10-695981","volume":"129","author":"JE Maxson","year":"2017","unstructured":"Maxson JE, Tyner JW. Genomics of chronic neutrophilic leukemia. Blood. 2017;129(6):715\u201322.","journal-title":"Blood."},{"issue":"3","key":"7130_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajh.24284","volume":"91","author":"MA Elliott","year":"2016","unstructured":"Elliott MA, Tefferi A. Chronic neutrophilic leukemia 2016: update on diagnosis, molecular genetics, prognosis, and management. Am J Hematol. 2016;91(3):341\u20139.","journal-title":"Am J Hematol"},{"issue":"9","key":"7130_CR21","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013;27(9):1870\u20133.","journal-title":"Leukemia."},{"issue":"19","key":"7130_CR22","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","volume":"368","author":"JE Maxson","year":"2013","unstructured":"Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368(19):1781\u201390.","journal-title":"N Engl J Med"},{"issue":"17","key":"7130_CR23","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","volume":"123","author":"SA Wang","year":"2014","unstructured":"Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, et al. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms. Blood. 2014;123(17):2645\u201351.","journal-title":"Blood."},{"issue":"2","key":"7130_CR24","first-page":"67","volume":"3","author":"KH Dao","year":"2014","unstructured":"Dao KH, Solti MB, Maxson JE, Winton EF, Press RD, Druker BJ, et al. Significant clinical response to JAK1\/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leuk Res Rep. 2014;3(2):67\u20139.","journal-title":"Leuk Res Rep"},{"issue":"6","key":"7130_CR25","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.3324\/haematol.2017.163790","volume":"102","author":"AS Gunawan","year":"2017","unstructured":"Gunawan AS, McLornan DP, Wilkins B, Waghorn K, Hoade Y, Cross NCP, et al. Ruxolitinib, a potent JAK1\/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia. Haematologica. 2017;102(6):e238\u2013e40.","journal-title":"Haematologica."},{"issue":"2","key":"7130_CR26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mhj.2002.123579","volume":"144","author":"A Schmermund","year":"2002","unstructured":"Schmermund A, Mohlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J. 2002;144(2):212\u20138.","journal-title":"Am Heart J"},{"issue":"7","key":"7130_CR27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc.2017.40","volume":"17","author":"MWN Deininger","year":"2017","unstructured":"Deininger MWN, Tyner JW, Solary E. Turning the tide in myelodysplastic\/myeloproliferative neoplasms. Nat Rev Cancer. 2017;17(7):425\u201340.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"7130_CR28","doi-asserted-by":"crossref","first-page":"015011","DOI":"10.1088\/1758-5082\/5\/1\/015011","volume":"5","author":"Y Zhong","year":"2013","unstructured":"Zhong Y, Ji B. Impact of cell shape on cell migration behavior on elastic substrate. Biofabrication. 2013;5(1):015011.","journal-title":"Biofabrication."},{"key":"7130_CR29","unstructured":"D\u2019Alessandro MP, Bergmann RA. Anatomy Atlases 1995 - 2019 [Available from: https:\/\/www.anatomyatlases.org\/."},{"issue":"3","key":"7130_CR30","doi-asserted-by":"crossref","first-page":"e0121546","DOI":"10.1371\/journal.pone.0121546","volume":"10","author":"MP Gustafson","year":"2015","unstructured":"Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, et al. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans. PLoS One. 2015;10(3):e0121546.","journal-title":"PLoS One"},{"issue":"2","key":"7130_CR31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.170.2.481","volume":"170","author":"JV Ravetch","year":"1989","unstructured":"Ravetch JV, Perussia B. Alternative membrane forms of fc gamma RIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med. 1989;170(2):481\u201397.","journal-title":"J Exp Med"},{"issue":"5","key":"7130_CR32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/art.10230","volume":"46","author":"G Fossati","year":"2002","unstructured":"Fossati G, Moots RJ, Bucknall RC, Edwards SW. Differential role of neutrophil Fc\u03b3 receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum. 2002;46(5):1351\u201361.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"7130_CR33","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.4049\/jimmunol.156.8.2866","volume":"156","author":"HS Warren","year":"1996","unstructured":"Warren HS, Altin JG, Waldron JC, Kinnear BF, Parish CR. A carbohydrate structure associated with CD15 (Lewis x) on myeloid cells is a novel ligand for human CD2. J Immunol. 1996;156(8):2866\u201373.","journal-title":"J Immunol"},{"issue":"7","key":"7130_CR34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/eji.1830190727","volume":"19","author":"KD Forsyth","year":"1989","unstructured":"Forsyth KD, Simpson AC, Levinsky RJ. CD15 antibodies increase neutrophil adhesion to endothelium by an LFA-1-dependent mechanism. Eur J Immunol. 1989;19(7):1331\u20134.","journal-title":"Eur J Immunol"},{"issue":"7","key":"7130_CR35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2019.04.013","volume":"40","author":"A Hidalgo","year":"2019","unstructured":"Hidalgo A, Chilvers ER, Summers C, Koenderman L. The neutrophil life cycle. Trends Immunol. 2019;40(7):584\u201397.","journal-title":"Trends Immunol"},{"issue":"1","key":"7130_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jlb.54.1.47","volume":"54","author":"F Lund-Johansen","year":"1993","unstructured":"Lund-Johansen F, Terstappen LW\u039cM. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol. 1993;54(1):47\u201355.","journal-title":"J Leukoc Biol"},{"issue":"15","key":"7130_CR37","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2016-09-687822","volume":"129","author":"R Avellino","year":"2017","unstructured":"Avellino R, Delwel R. Expression and regulation of C\/EBP\u03b1 in normal myelopoiesis and in malignant transformation. Blood. 2017;129(15):2083\u201391.","journal-title":"Blood."},{"issue":"4","key":"7130_CR38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-04-1816","volume":"11","author":"L-I Lin","year":"2005","unstructured":"Lin L-I, Chen C-Y, Lin D-T, Tsay W, Tang J-L, Yeh Y-C, et al. Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have Biallelic mutations and show a distinct Immunophenotype of the leukemic cells. Clin Cancer Res. 2005;11(4):1372\u20139.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"7130_CR39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1947601911411084","volume":"2","author":"A Fernandez-Medarde","year":"2011","unstructured":"Fernandez-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer. 2011;2(3):344\u201358.","journal-title":"Genes Cancer"},{"issue":"26","key":"7130_CR40","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1182\/blood-2012-12-475863","volume":"121","author":"J Wang","year":"2013","unstructured":"Wang J, Kong G, Liu Y, Du J, Chang Y-I, Tey SR, et al. NrasG12D\/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions. Blood. 2013;121(26):5203\u20137.","journal-title":"Blood."},{"issue":"4","key":"7130_CR41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/cam4.1030","volume":"6","author":"S Liu","year":"2017","unstructured":"Liu S, Gao G, Yan D, Chen X, Yao X, Guo S, et al. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K\/AKT pathways. Cancer Med. 2017;6(4):819\u201333.","journal-title":"Cancer Med"},{"issue":"5","key":"7130_CR42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni.2258","volume":"13","author":"X Liu","year":"2012","unstructured":"Liu X, Ma B, Malik AB, Tang H, Yang T, Sun B, et al. Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. Nat Immunol. 2012;13(5):457\u201364.","journal-title":"Nat Immunol"},{"key":"7130_CR43","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/leu.2016.155","volume":"30","author":"J Rudolph","year":"2016","unstructured":"Rudolph J, Heine A, Quast T, Kolanus W, Trebicka J, Brossart P, et al. The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK. Leukemia. 2016;30:2119.","journal-title":"Leukemia."},{"issue":"30","key":"7130_CR44","doi-asserted-by":"crossref","first-page":"29573","DOI":"10.18632\/oncotarget.4998","volume":"6","author":"JA Machado-Neto","year":"2015","unstructured":"Machado-Neto JA, de Melo CP, Favaro P, Lazarini M. da Silva Santos Duarte a, Lorand-Metze I, et al. Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. Oncotarget. 2015;6(30):29573\u201384.","journal-title":"Oncotarget."},{"issue":"6","key":"7130_CR45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nri.2016.49","volume":"16","author":"S de Oliveira","year":"2016","unstructured":"de Oliveira S, Rosowski EE, Huttenlocher A. Neutrophil migration in infection and wound repair: going forward in reverse. Nat Rev Immunol. 2016;16(6):378\u201391.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"7130_CR46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1615\/CritRevImmunol.v26.i4.20","volume":"26","author":"Y Kobayashi","year":"2006","unstructured":"Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol. 2006;26(4):307\u201316.","journal-title":"Crit Rev Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07130-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07130-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T01:14:00Z","timestamp":1696382040000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07130-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7130"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07130-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16153\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16153\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16153\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments involving human material were performed with approval of the ethics committee of the Medical Faculty, University Hospital Essen, Germany. Identification numbers of ethical approvals\/registers: 15\u20136686-BO (HNMR samples and transfusion medicine samples, Essen, Germany), 16\u20136982-BO (aCML samples, Essen, Germany). Written informed consent was obtained from all participants including the aCML patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}